Literature DB >> 25287440

Conditional survival after surgical resection of gastric cancer: a multi-institutional analysis of the us gastric cancer collaborative.

Yuhree Kim1, Aslam Ejaz, Gaya Spolverato, Malcolm H Squires, George Poultsides, Ryan C Fields, Mark Bloomston, Sharon M Weber, Konstantinos Votanopoulos, Alexandra W Acher, Linda X Jin, William G Hawkins, Carl Schmidt, David Kooby, David Worhunsky, Neil Saunders, Clifford S Cho, Edward A Levine, Shishir K Maithel, Timothy M Pawlik.   

Abstract

BACKGROUND: Survival estimates following surgical resection of gastric adenocarcinoma are traditionally reported as survival from the date of surgery. Conditional survival (CS) estimates, however, may be more clinically relevant by accounting for time already survived. We assessed CS following surgical resection for gastric adenocarcinoma.
METHODS: We analyzed 807 patients who underwent resection for gastric adenocarcinoma from 2000 to 2012 at seven participating institutions in the U.S. Gastric Cancer Collaborative. Cox proportional hazards models were used to evaluate factors associated with overall survival. Three-year CS estimates at "x" year after surgery were calculated as follows: CS3 = S(x+3)/S(x).
RESULTS: Overall 1-, 3-, and 5-year overall survival rates after gastric resection were 42, 34, and 30 %, respectively. Using CS estimates, the probability of surviving an additional 3 years given that the patient had survived at 1, 3, and 5 years were 56, 71, and 82 %, respectively. Patients with higher risk at baseline (i.e., stage III or IV disease, lymphovascular invasion) demonstrated the greatest increase in CS over time.
CONCLUSIONS: Survival estimates following surgical resection of gastric adenocarcinoma is dynamic; the probability of survival increases with time already survived. Patients with worse prognostic features at the time of surgery had the greatest increases in CS over time. Conditional survival estimates provide important information about the changing probability of survival over time and should be used among patients with resected gastric adenocarcinoma to guide subsequent follow-up strategies.

Entities:  

Mesh:

Year:  2014        PMID: 25287440     DOI: 10.1245/s10434-014-4116-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  26 in total

1.  Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma.

Authors:  Stefan Buettner; Georgios Antonios Margonis; Yuhree Kim; Faiz Gani; Cecilia G Ethun; George A Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  Ann Surg Oncol       Date:  2016-08-05       Impact factor: 5.344

2.  Stomach cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.

Authors:  Melissa A Jim; Paulo S Pinheiro; Helena Carreira; David K Espey; Charles L Wiggins; Hannah K Weir
Journal:  Cancer       Date:  2017-12-15       Impact factor: 6.860

3.  Short-term and long-term risk factors in gastric cancer.

Authors:  Giuseppe Verlato; Daniele Marrelli; Simone Accordini; Maria Bencivenga; Alberto Di Leo; Alberto Marchet; Roberto Petrioli; Giacomo Zoppini; Michele Muggeo; Franco Roviello; Giovanni de Manzoni
Journal:  World J Gastroenterol       Date:  2015-06-07       Impact factor: 5.742

4.  The Optimal Timing of Stage 2 Palliation for Hypoplastic Left Heart Syndrome: An Analysis of the Pediatric Heart Network Single Ventricle Reconstruction Trial Public Data Set.

Authors:  James M Meza; Edward J Hickey; Eugene H Blackstone; Robert D B Jaquiss; Brett R Anderson; William G Williams; Sally Cai; Glen S Van Arsdell; Tara Karamlou; Brian W McCrindle
Journal:  Circulation       Date:  2017-07-07       Impact factor: 29.690

5.  Prediction model of objective response after neoadjuvant chemotherapy in patients with locally advanced gastric cancer.

Authors:  Wei Xu; Zhiyuan Fan; Lingquan Wang; Changyu He; Zhentian Ni; Zichen Hua; Zhenglun Zhu; Zhongyin Yang; Yanan Zheng; Runhua Feng; Chao Yan; Chen Li; Xuexin Yao; Mingmin Chen; Min Yan; Zhenggang Zhu; Wentao Liu
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

6.  Predictors of Metastatic Lymph Nodes at Preoperative Staging CT in Gastric Adenocarcinoma.

Authors:  Filippo Crimì; Quoc Riccardo Bao; Valentina Mari; Chiara Zanon; Giulio Cabrelle; Gaya Spolverato; Salvatore Pucciarelli; Emilio Quaia
Journal:  Tomography       Date:  2022-04-22

7.  Effect of Short-Term Preoperative Parenteral Nutrition Support for Gastric Cancer Patients with Sarcopenia: a Propensity Score Matching Analysis.

Authors:  Ze-Xin Huang; Hui-Hui Zhang; Wei-Teng Zhang; Ming-Ming Shi; Jia-Huan Ren; Li-Bin Xu; Xiao-Dong Chen; Guan-Bao Zhu
Journal:  J Gastrointest Surg       Date:  2022-01-29       Impact factor: 3.267

8.  Conditional Survival and Time of Biochemical Recurrence of Localized Prostate Cancer in Japanese Patients Undergoing Laparoscopic Radical Prostatectomies.

Authors:  Masayoshi Kawakami; Masanori Hasegawa; Koichiro Yamada; Keisuke Shigeta; Izumi Hanada; Tatsuya Otaki; Kentaro Nagao; Tatsuya Umemoto; Yuuki Shimizu; Hakushi Kim; Nobuyuki Nakajima; Masahiro Nitta; Kazuya Hanai; Yoshiaki Kawamura; Sunao Shoji; Akira Miyajima
Journal:  Ann Surg Oncol       Date:  2020-07-10       Impact factor: 5.344

9.  Conditional probability of long-term survival after resection of hilar cholangiocarcinoma.

Authors:  Stefan Buettner; Georgios A Margonis; Yuhree Kim; Faiz Gani; Cecilia G Ethun; George Poultsides; Thuy Tran; Kamran Idrees; Chelsea A Isom; Ryan C Fields; Bradley Krasnick; Sharon M Weber; Ahmed Salem; Robert C G Martin; Charles R Scoggins; Perry Shen; Harveshp D Mogal; Carl Schmidt; Eliza Beal; Ioannis Hatzaras; Rivfka Shenoy; Shishir K Maithel; Timothy M Pawlik
Journal:  HPB (Oxford)       Date:  2016-04-24       Impact factor: 3.647

10.  Evaluation of Human Epidermal Growth Factor Receptor 2 Overexpression, Clinicopathological Characteristics, and Factors Affecting Survival in Gastric Cancer.

Authors:  Ozde Melisa Celayir; Fatih Selcukbiricik; Canan Tanik; Yuksel Altuntas
Journal:  Sisli Etfal Hastan Tip Bul       Date:  2021-07-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.